136 related articles for article (PubMed ID: 38615609)
1. Xanthohumol, a prenylated chalcone, regulates lipid metabolism by modulating the LXRα/RXR-ANGPTL3-LPL axis in hepatic cell lines and high-fat diet-fed zebrafish models.
Gao WY; Chen PY; Hsu HJ; Liou JW; Wu CL; Wu MJ; Yen JH
Biomed Pharmacother; 2024 May; 174():116598. PubMed ID: 38615609
[TBL] [Abstract][Full Text] [Related]
2. The Citrus Flavonoid Nobiletin Downregulates Angiopoietin-like Protein 3 (ANGPTL3) Expression and Exhibits Lipid-Modulating Effects in Hepatic Cells and Adult Zebrafish Models.
Lin CY; Chen PY; Hsu HJ; Gao WY; Wu MJ; Yen JH
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293338
[TBL] [Abstract][Full Text] [Related]
3. The Lipid-Modulating Effect of Tangeretin on the Inhibition of Angiopoietin-like 3 (ANGPTL3) Gene Expression through Regulation of LXRα Activation in Hepatic Cells.
Chen PY; Chao TY; Hsu HJ; Wang CY; Lin CY; Gao WY; Wu MJ; Yen JH
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576019
[TBL] [Abstract][Full Text] [Related]
4. Physical and functional interactions between nuclear receptor LXRα and the forkhead box transcription factor FOXA2 regulate the response of the human lipoprotein lipase gene to oxysterols in hepatic cells.
Kanaki M; Tiniakou I; Thymiakou E; Kardassis D
Biochim Biophys Acta Gene Regul Mech; 2017 Aug; 1860(8):848-860. PubMed ID: 28576574
[TBL] [Abstract][Full Text] [Related]
5. Physiological roles and regulation of hepatic angiopoietin-like protein 3 in Japanese Black cattle (Bos taurus) during the fattening period.
Shikida R; Kim M; Futohashi M; Nishihara K; Lee H; Suzuki Y; Baek Y; Masaki T; Ikuta K; Iwamoto E; Uemoto Y; Haga S; Terada F; Roh S
J Anim Sci; 2023 Jan; 101():. PubMed ID: 37317898
[TBL] [Abstract][Full Text] [Related]
6. Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor.
Inaba T; Matsuda M; Shimamura M; Takei N; Terasaka N; Ando Y; Yasumo H; Koishi R; Makishima M; Shimomura I
J Biol Chem; 2003 Jun; 278(24):21344-51. PubMed ID: 12672813
[TBL] [Abstract][Full Text] [Related]
7. Xanthohumol Suppresses Mylip/Idol Gene Expression and Modulates LDLR Abundance and Activity in HepG2 Cells.
Chen SF; Chen PY; Hsu HJ; Wu MJ; Yen JH
J Agric Food Chem; 2017 Sep; 65(36):7908-7918. PubMed ID: 28812343
[TBL] [Abstract][Full Text] [Related]
8. Liver X receptor and retinoic X receptor agonists modulate the expression of genes involved in lipid metabolism in human endothelial cells.
Norata GD; Ongari M; Uboldi P; Pellegatta F; Catapano AL
Int J Mol Med; 2005 Oct; 16(4):717-22. PubMed ID: 16142410
[TBL] [Abstract][Full Text] [Related]
9. Suppression of up-regulated LXRα by silybin ameliorates experimental rheumatoid arthritis and abnormal lipid metabolism.
Xie Y; Feng SL; Mai CT; Zheng YF; Wang H; Liu ZQ; Zhou H; Liu L
Phytomedicine; 2021 Jan; 80():153339. PubMed ID: 33038868
[TBL] [Abstract][Full Text] [Related]
10. Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolism.
Wen Y; Chen YQ; Konrad RJ
Curr Opin Lipidol; 2024 Apr; 35(2):58-65. PubMed ID: 37962908
[TBL] [Abstract][Full Text] [Related]
11. Targeting the Liver-Brain Axis with Hop-Derived Flavonoids Improves Lipid Metabolism and Cognitive Performance in Mice.
Paraiso IL; Revel JS; Choi J; Miranda CL; Lak P; Kioussi C; Bobe G; Gombart AF; Raber J; Maier CS; Stevens JF
Mol Nutr Food Res; 2020 Aug; 64(15):e2000341. PubMed ID: 32627931
[TBL] [Abstract][Full Text] [Related]
12. Identification of a new functional domain in angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL).
Lee EC; Desai U; Gololobov G; Hong S; Feng X; Yu XC; Gay J; Wilganowski N; Gao C; Du LL; Chen J; Hu Y; Zhao S; Kirkpatrick L; Schneider M; Zambrowicz BP; Landes G; Powell DR; Sonnenburg WK
J Biol Chem; 2009 May; 284(20):13735-13745. PubMed ID: 19318355
[TBL] [Abstract][Full Text] [Related]
13. Effects of xanthohumol-rich extract from the hop on fatty acid metabolism in rats fed a high-fat diet.
Yui K; Kiyofuji A; Osada K
J Oleo Sci; 2014; 63(2):159-68. PubMed ID: 24420065
[TBL] [Abstract][Full Text] [Related]
14. Genetic Mimicry Analysis Reveals the Specific Lipases Targeted by the ANGPTL3-ANGPTL8 Complex and ANGPTL4.
Landfors F; Chorell E; Kersten S
J Lipid Res; 2023 Jan; 64(1):100313. PubMed ID: 36372100
[TBL] [Abstract][Full Text] [Related]
15. Angiopoietin-Like Protein 3 (ANGPTL3) Modulates Lipoprotein Metabolism and Dyslipidemia.
Chen PY; Gao WY; Liou JW; Lin CY; Wu MJ; Yen JH
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298929
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: New therapeutic approaches for the treatment of atherogenic dyslipidemia.
Ruscica M; Zimetti F; Adorni MP; Sirtori CR; Lupo MG; Ferri N
Pharmacol Res; 2020 Mar; 153():104653. PubMed ID: 31931117
[TBL] [Abstract][Full Text] [Related]
17. ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase.
Chi X; Britt EC; Shows HW; Hjelmaas AJ; Shetty SK; Cushing EM; Li W; Dou A; Zhang R; Davies BSJ
Mol Metab; 2017 Oct; 6(10):1137-1149. PubMed ID: 29031715
[TBL] [Abstract][Full Text] [Related]
18. Angiopoietin-like proteins and postprandial partitioning of fatty acids.
DiDonna NM; Chen YQ; Konrad RJ
Curr Opin Lipidol; 2022 Feb; 33(1):39-46. PubMed ID: 34789669
[TBL] [Abstract][Full Text] [Related]
19. ANGPTL3 is part of the machinery causing dyslipidemia majorily via LPL inhibition in mastitis mice.
Xiao HB; Wang JY; Sun ZL
Exp Mol Pathol; 2017 Dec; 103(3):242-248. PubMed ID: 29104012
[TBL] [Abstract][Full Text] [Related]
20. Daming capsule, a hypolipidaemic drug, lowers blood lipids by activating the AMPK signalling pathway.
Bian Y; Li X; Li X; Ju J; Liang H; Hu X; Dong L; Wang N; Li J; Zhang Y; Yang B
Biomed Pharmacother; 2019 Sep; 117():109176. PubMed ID: 31387185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
